Sihf Healthcare - Red Bud Family Medicine Medicare: Medicare Enrolled Practice Location: 824 Locust St, Red Bud, IL 62278 Phone: 618-282-6656 |
Red Bud Health Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 325 Spring St, Red Bud, IL 62278 Phone: 618-282-7373 |
Drs Pichet & Meechai Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 415 W S Fourth St, Suite A, Red Bud, IL 62278 Phone: 618-282-3883 Fax: 618-282-6133 |
Older Adult Health Center Family Medicine Medicare: Medicare Enrolled Practice Location: 325 Spring St, Red Bud, IL 62278 Phone: 618-282-3831 |
Deaconess Illinois Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 325 Spring St, Red Bud, IL 62278 Phone: 618-939-2273 Fax: 618-939-0245 |
Deaconess Il Specialty Spring St Multispecialty Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 W South 1st St, Red Bud, IL 62278 Phone: 618-282-7373 Fax: 618-282-7376 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates.
Scientists had long believed that the normal lining of the female vaginal tract was an effective barrier to invasion of the HIV virus during sexual intercourse. They thought the large HIV virus couldn't penetrate the tissue.
A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.
Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-ever analysis of the cancer's genetic biomarkers, reported in Nature Genetics today.
› Verified 2 days ago